Frontlight ResearchEarly access
Acute myeloid leukaemia trials in Czechia
10 of 12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Brno, Ostrava, Prague
- Age
- 18 years and over
- People
- 1,300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - Phase 3Taking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Brno, Hradec Králové, Ostrava - Poruba, Pilsen, Prague
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - Phase 3Taking peopleIMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Where
- Brno, Novy Hradec Kralove, Olomouc, Ostrava, Plzen 23, Prague
- Age
- 18 years and over
- People
- 339 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06713837 · EU 2024-514517-35-00 - Phase 3CompletedStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Brno, Ostrava
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - Phase 2/3Taking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Brno, Ostrava, Prague, Prague 2
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - Phase 2/3Taking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Hradec Králové
- Age
- 18 years to 80 years
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - Phase 2Not yet taking people in CzechiaRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Prague
- Age
- Up to 64 years
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00 - Phase 1Not yet taking people in CzechiaA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Prague
- Age
- Up to 17 years
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - Phase 1/2Taking peopleProton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
- Where
- Prague
- Age
- 18 years to 65 years
- People
- 16
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT07532824 - Phase 2Active, not recruitingTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Brno, Prague
- Age
- Up to 18 years
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00